Cardiovascular Effects of Autologous Bone Marrow–Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study

Cardiovascular Effects of Autologous Bone Marrow–Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study

Background After renal transplantation, there is a need of immunosuppressive regimens that effectively prevent allograft rejection while minimizing cardiovascular complications. This substudy of the TRITON trial evaluated the cardiovascular effects of autologous bone marrow–derived mesenchymal strom...

Full description

Bibliographic Details
Main Authors: Maria Chiara Meucci, Marlies E. J. Reinders, Koen E. Groeneweg, Suzanne Bezstarosti, Nina Ajmone Marsan, Jeroen J. Bax, Johan W. De Fijter, Victoria Delgado
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
immunosuppression
left ventricular diastolic function
left ventricular hypertrophy
mesenchymal stem cells
renal transplantation
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.023300

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.023300

Similar Items